SUNOSI
Identification of Sunosi
| No description |
Google image searchProduct monograph
Active ingredient
solriamfetol (solriamfetol hydrochloride), 150 MG
DIN: 02515822
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: AXSOME MALTA LTD.
Date: 17-NOV-2022
ATC:
- N06 — PSYCHOANALEPTICS (ATC, ATC/DDD, )
- N06B — PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS (ATC, ATC/DDD)
- N06BA — Centrally acting sympathomimetics (ATC, ATC/DDD)
- N06BA14 — SOLRIAMFETOL (ATC/DDD)
